These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Focused chemical libraries--design and enrichment: an example of protein-protein interaction chemical space. Zhang X; Betzi S; Morelli X; Roche P Future Med Chem; 2014 Jul; 6(11):1291-307. PubMed ID: 24773599 [TBL] [Abstract][Full Text] [Related]
7. 2P2Idb: a structural database dedicated to orthosteric modulation of protein-protein interactions. Basse MJ; Betzi S; Bourgeas R; Bouzidi S; Chetrit B; Hamon V; Morelli X; Roche P Nucleic Acids Res; 2013 Jan; 41(Database issue):D824-7. PubMed ID: 23203891 [TBL] [Abstract][Full Text] [Related]
8. Computational probing protein-protein interactions targeting small molecules. Wang YC; Chen SL; Deng NY; Wang Y Bioinformatics; 2016 Jan; 32(2):226-34. PubMed ID: 26415726 [TBL] [Abstract][Full Text] [Related]
9. Exploring the chemical space of protein-protein interaction inhibitors through machine learning. Choi J; Yun JS; Song H; Kim NH; Kim HS; Yook JI Sci Rep; 2021 Jun; 11(1):13369. PubMed ID: 34183730 [TBL] [Abstract][Full Text] [Related]
10. RVMAB: Using the Relevance Vector Machine Model Combined with Average Blocks to Predict the Interactions of Proteins from Protein Sequences. An JY; You ZH; Meng FR; Xu SJ; Wang Y Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213337 [TBL] [Abstract][Full Text] [Related]
11. Benchmark Study Based on 2P2I Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886 [TBL] [Abstract][Full Text] [Related]
13. [Chemical libraries dedicated to protein-protein interactions]. Sperandio O; Villoutreix BO; Morelli X; Roche P Med Sci (Paris); 2015 Mar; 31(3):312-9. PubMed ID: 25855285 [TBL] [Abstract][Full Text] [Related]
14. Imbalance in chemical space: How to facilitate the identification of protein-protein interaction inhibitors. Kuenemann MA; Labbé CM; Cerdan AH; Sperandio O Sci Rep; 2016 Apr; 6():23815. PubMed ID: 27034268 [TBL] [Abstract][Full Text] [Related]
15. Assessing the druggability of protein-protein interactions by a supervised machine-learning method. Sugaya N; Ikeda K BMC Bioinformatics; 2009 Aug; 10():263. PubMed ID: 19703312 [TBL] [Abstract][Full Text] [Related]
16. PCVMZM: Using the Probabilistic Classification Vector Machines Model Combined with a Zernike Moments Descriptor to Predict Protein-Protein Interactions from Protein Sequences. Wang Y; You Z; Li X; Chen X; Jiang T; Zhang J Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492483 [TBL] [Abstract][Full Text] [Related]
17. Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations. Buchwald P IUBMB Life; 2010 Oct; 62(10):724-31. PubMed ID: 20979208 [TBL] [Abstract][Full Text] [Related]
18. Rationalizing the chemical space of protein-protein interaction inhibitors. Sperandio O; Reynès CH; Camproux AC; Villoutreix BO Drug Discov Today; 2010 Mar; 15(5-6):220-9. PubMed ID: 19969101 [TBL] [Abstract][Full Text] [Related]
19. Application of support vector machine to three-dimensional shape-based virtual screening using comprehensive three-dimensional molecular shape overlay with known inhibitors. Sato T; Yuki H; Takaya D; Sasaki S; Tanaka A; Honma T J Chem Inf Model; 2012 Apr; 52(4):1015-26. PubMed ID: 22424085 [TBL] [Abstract][Full Text] [Related]
20. Application of Machine Learning Approaches for Protein-protein Interactions Prediction. Zhang M; Su Q; Lu Y; Zhao M; Niu B Med Chem; 2017; 13(6):506-514. PubMed ID: 28530547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]